Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.11, 2000-11, pp. : 2601-2617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

By Drucker DJ

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 87-100

Informa Healthcare

Access to resources Recommend Favorite

ACE inhibitors: a `prudent' approach in type 2 diabetes?

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes Mellitus

By Neumiller Joshua J.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 377-385

Adis International

Access to resources Recommend Favorite

Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes

By Augustyns Koen Van der Veken Pieter Senten Kristel Haemers Achiel

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 499-510

Informa Healthcare

Access to resources Recommend Favorite

PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity

By Zhang Zhong-Yin Lee Seung-Yub

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 223-233

Informa Healthcare

Access to resources Recommend Favorite